Current diagnosis and treatment of leptomeningeal metastasis
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 38 (2/3) , 245-252
- https://doi.org/10.1023/a:1005956925637
Abstract
Meningeal metastasis occurs in 3–8% of all cancer patients, producing neurologic morbidity and a high mortality. Diagnosis is best established by the demonstration of malignant cells in the...Keywords
This publication has 30 references indexed in Scilit:
- Meningeal carcinomatosis: CSF cytology, immunocytochemistry and biochemical tumor markersActa Neurologica Scandinavica, 2009
- Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barre syndromeNeurology, 1996
- Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasisAnnals of Neurology, 1995
- Clinical Outcome in Aggressively Treated Meningeal CarcinomatosisArchives of Neurology, 1994
- MRI changes in intracranial hypotensionNeurology, 1993
- Intrathecal Dacarbazine Treatment of Leptomeningeal Malignant MelanomaJNCI Journal of the National Cancer Institute, 1992
- Leptomeningeal metastasesNeurology, 1991
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitisThe American Journal of Medicine, 1982
- Cerebrospinal fluid biochemical markers of central nervous system metastasesAnnals of Neurology, 1980